Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2011; 17(27): 3248-3256
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3248
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3248
Table 4 Subgroup analysis of the association between GSTT1 polymorphism and hepatocellular carcinoma risk
| Group | No. of studies (cases/controls) | Statistical method | OR (95% CI) | P |
| All studies | 16 (2410/3669) | Random | 1.510 (1.236-1.845) | 0.000 |
| Residence area of the subjects | ||||
| High-incidence area | 10 (1418/2489) | Random | 1.641 (1.328-2.027) | 0.000 |
| Low-incidence area | 5 (882/1068) | Random | 1.152 (0.777-1.707) | 0.483 |
| Mixed areas | 1 (110/112) | - | 2.234 (1.305-3.825) | 0.003 |
| Number of cases | ||||
| < 100 | 7 (502/949) | Random | 1.617 (1.035-2.528) | 0.035 |
| ≥ 100 | 9 (1908/2720) | Random | 1.457 (1.173-1.810) | 0.001 |
| Source of controls | ||||
| Population-based | 9 (1484/1465) | Random | 1.441 (1.039-1.997) | 0.028 |
| Hospital-based | 7 (926/2204) | Fixed | 1.635 (1.391-1.921) | 0.000 |
-
Citation: Yu L, Wang CY, Xi B, Sun L, Wang RQ, Yan YK, Zhu LY.
GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World J Gastroenterol 2011; 17(27): 3248-3256 - URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3248.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3248